全球心肌肌鈣蛋白市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，心臟肌鈣蛋白市場規模將從 2025 年的 59.3 億美元成長至 133 億美元，2026 年至 2034 年的複合年成長率為 9.39%。

由於心血管疾病發生率不斷上升以及快速診斷檢測在心臟病發作中的重要性日益凸顯，全球心肌肌鈣蛋白市場正經歷強勁成長。心肌肌鈣蛋白檢測是一種廣泛用於檢測心肌損傷和診斷急性冠狀動脈症候群的生物標記。其高靈敏度和特異性使其成為現代心臟診斷的關鍵要素。

推動市場成長的因素之一是全球心臟病負擔日益加重，這源自於人口老化、久坐不動的生活方式以及糖尿病和肥胖症發病率上升等因素。醫院和急診室越來越依賴高敏感性肌鈣蛋白檢測來快速診斷心臟事件並啟動適當的治療。

受診斷技術不斷進步的推動，心肌肌鈣蛋白市場預計未來將持續成長。高靈敏度就地檢驗設備的研發將使心臟疾病的檢測更加快速且準確。隨著醫療系統日益重視早期診斷和快速干涉，對心肌肌鈣蛋白檢測的需求預計將顯著增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球心肌肌鈣蛋白市場：依肌鈣蛋白類型分類

• 市場分析、洞察與預測
• 肌鈣蛋白 I
• 肌鈣蛋白T
• 肌鈣蛋白C

第5章：全球心肌肌鈣蛋白市場：依工廠分類

• 市場分析、洞察與預測
• 檢查室/中心實驗室
• 即時偵測 (POC)

第6章：全球心肌肌鈣蛋白市場：依適應症分類

• 市場分析、洞察與預測
• 心肌梗塞
• 鬱血性心臟衰竭
• 急性冠狀動脈症候群
• 其他（例如，心肌病）

第7章 全球心肌肌鈣蛋白市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 居家醫療環境
• 其他（研究機構等）

第8章 全球心肌肌鈣蛋白市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche Ltd
  • BioMAfA（C）Rieux SA
  • Abbott Laboratories
  • Siemens Healthineers India
  • Eurolyser Diagnostica GmbH
  • QuidelOrtho Corporation
  • Beckman Coulter Inc
  • Response Biomedical Corporation
  • LifeSign LLC

The Cardiac Troponin Market size is expected to reach USD 13.30 Billion in 2034 from USD 5.93 Billion (2025) growing at a CAGR of 9.39% during 2026-2034.

The Global Cardiac Troponin Market is experiencing strong growth due to the increasing incidence of cardiovascular diseases and the rising importance of rapid diagnostic testing for heart attacks. Cardiac troponin tests are widely used biomarkers for detecting myocardial injury and diagnosing acute coronary syndromes. Their high sensitivity and specificity make them a critical component of modern cardiac diagnostics.

One of the primary drivers of the market is the growing burden of heart disease worldwide, driven by factors such as aging populations, sedentary lifestyles, and rising rates of diabetes and obesity. Hospitals and emergency departments increasingly rely on high-sensitivity troponin assays to quickly diagnose cardiac events and initiate appropriate treatment.

In the future, the cardiac troponin market is expected to grow with continued advancements in diagnostic technologies. The development of highly sensitive point-of-care testing devices will enable faster and more accurate detection of cardiac conditions. As healthcare systems emphasize early diagnosis and rapid intervention, the demand for cardiac troponin testing is projected to increase significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Troponin Type

• Troponin I
• Troponin T
• Troponin C

By Setting

• Laboratory Setting
• Point-of-Care (POC) Testing

By Indication

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Others (Cardiomyopathy, etc.)

By End-user

• Hospitals & Clinics
• Diagnostic Laboratories
• Homecare Settings
• Others (Research Institutes, etc.)

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, bioMrieux SA, Abbott Laboratories, Siemens Healthineers India, Eurolyser Diagnostica GmbH, QuidelOrtho Corporation, Beckman Coulter Inc, Response Biomedical Corporation, LifeSign LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC TROPONIN MARKET: BY TROPONIN TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Troponin Type
• 4.2. Troponin I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Troponin T Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Troponin C Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC TROPONIN MARKET: BY SETTING 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Setting
• 5.2. Laboratory Setting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-of-Care (POC) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC TROPONIN MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Myocardial Infarction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Congestive Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Acute Coronary Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others (Cardiomyopathy, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC TROPONIN MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others (Research Institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIAC TROPONIN MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Troponin Type
  • 8.2.2 By Setting
  • 8.2.3 By Indication
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Troponin Type
  • 8.3.2 By Setting
  • 8.3.3 By Indication
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Troponin Type
  • 8.4.2 By Setting
  • 8.4.3 By Indication
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Troponin Type
  • 8.5.2 By Setting
  • 8.5.3 By Indication
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Troponin Type
  • 8.6.2 By Setting
  • 8.6.3 By Indication
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIAC TROPONIN INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche Ltd
  • 10.2.2 BioMAfA(C)Rieux SA
  • 10.2.3 Abbott Laboratories
  • 10.2.4 Siemens Healthineers India
  • 10.2.5 Eurolyser Diagnostica GmbH
  • 10.2.6 QuidelOrtho Corporation
  • 10.2.7 Beckman Coulter Inc
  • 10.2.8 Response Biomedical Corporation
  • 10.2.9 LifeSign LLC